Prevalent Closes H1 2023 with Record-Setting Revenue Growth
Three Quarters of All New Customers Leverage Continuous Monitoring with Assessments, Demonstrating the Unique Value of Prevalent's Comprehensive TPRM Solution
PHOENIX, July 17, 2023 /PRNewswire/ -- Prevalent, Inc., the company that takes the pain out of third-party risk management (TPRM), today announced a record-breaking start to 2023 with tremendous customer traction and revenue growth. Continuing momentum from Q1 2023, Prevalent:
Grew new business billings 51% over H1 2022, driven by a strong mix of new logos and existing customer expansion
Increased annual recurring revenue (ARR) by 28% over H1 2022
Achieved a 73% attachment rate of new customers purchasing Vendor Threat Monitor, further validating that organizations want a single solution for assessment and continuous monitoring
"We have continued to grow at a remarkable rate year over year," stated Kevin Hickey, CEO of Prevalent, Inc. "The team has done an exceptional job not only getting ahead of changes in the market, but also delivering innovative solutions to meet customer requirements in this dynamic environment. As regulatory requirements expand and security incidents continue to grow, we are committed to providing the most comprehensive TPRM platform to help organizations reduce risk and maintain the highest level of resiliency."
Partnered with IBM to build cyber resilience into supplier ecosystems, protecting critical supply chains and third-party ecosystems with expert security services and software.
Issued free resources to help customers mitigate risks from the 3CX, MOVEit and NBA breaches.
About Prevalent Prevalent takes the pain out of third-party risk management (TPRM). Companies use our software and services to eliminate the security and compliance exposures that come from working with vendors and suppliers throughout the third-party risk management lifecycle. Our customers benefit from a flexible, hybrid approach to TPRM, where they not only gain solutions tailored to their needs, but also realize a rapid return on investment. Regardless of where they start, we help our customers stop the pain, make informed decisions, and adapt and mature their TPRM programs over time.
Media Contact Angelique Faul, Silver Jacket Communications, 513-633-0897, [email protected]
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from a real-world patient cohort review of JELMYTO...
With a remarkable achievement of 81.556 billion yuan in operating revenue, marking an 11.74% increase from the previous year, and a net profit attributable to shareholders of 7.039 billion yuan, soaring by 27.21%, JA Solar hit historic highs in both...
Leading research and experience management firm Sogolytics will showcase innovations in HR and employee experience at UNLEASH America next week.
"With such a rapid evolution in the world of HR tech, we're seeing some major changes in how employers...
RaySearch Laboratories AB (publ) and C-RAD are pleased to announce a collaboration agreement, aiming at jointly developing innovative solutions and products to enhance the quality of radiation therapy.
The focus of the collaboration is to...